Cresco Labs, Inc. (CRLBF)
0.6438
+0.01
(+1.23%)
USD |
OTCM |
Oct 09, 16:00
Cresco Labs EPS Diluted (Quarterly) : 0.0356 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0356 |
| March 31, 2026 | -0.0359 |
| December 31, 2025 | -0.2433 |
| September 30, 2025 | -0.048 |
| June 30, 2025 | -0.0461 |
| March 31, 2025 | -0.0412 |
| December 31, 2024 | -0.0125 |
| September 30, 2024 | -0.0303 |
| June 30, 2024 | -0.1575 |
| March 31, 2024 | -0.0152 |
| December 31, 2023 | 0.0077 |
| September 30, 2023 | -0.3425 |
| June 30, 2023 | -0.1165 |
| March 31, 2023 | -0.0855 |
| December 31, 2022 | -0.5347 |
| September 30, 2022 | -0.0325 |
| June 30, 2022 | -0.0457 |
| March 31, 2022 | -0.0935 |
| December 31, 2021 | -0.0512 |
| September 30, 2021 | -0.998 |
| June 30, 2021 | -0.0186 |
| March 31, 2021 | -0.1237 |
| December 31, 2020 | -0.244 |
| September 30, 2020 | 0.0424 |
| June 30, 2020 | -0.1766 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1342 |
| December 31, 2019 | -0.212 |
| September 30, 2019 | -0.0602 |
| June 30, 2019 | -0.0179 |
| March 31, 2019 | -0.055 |
| December 31, 2018 | -0.0237 |
| January 31, 2018 | -1.130 |
| October 31, 2017 | -0.39 |
| July 31, 2017 | -0.449 |
| April 30, 2017 | -0.3846 |
| January 31, 2017 | -1.896 |
| October 31, 2016 | -0.2356 |
| July 31, 2016 | -0.533 |
| April 30, 2016 | -0.4098 |
| January 31, 2016 | -0.5918 |
| October 31, 2015 | -0.3211 |
| July 31, 2015 | 3.002 |
| April 30, 2015 | -0.6507 |
| January 31, 2015 | -1.827 |
| October 31, 2014 | -0.875 |
| July 31, 2014 | -0.7586 |
| April 30, 2014 | -0.5149 |
| January 31, 2014 | -2.280 |
| October 31, 2013 | -1.786 |
| July 31, 2013 | -1.143 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| cbdMD, Inc. | -0.1129 |
| Trulieve Cannabis Corp. | -2.107 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.37M |
| Revenue (Quarterly) | 173.34M |
| Total Expenses (Quarterly) | 156.54M |
| Enterprise Value | 672.28M |
| Gross Profit Margin (Quarterly) | 46.49% |
| Profit Margin (Quarterly) | 8.87% |
| Earnings Yield | -45.29% |
| Operating Earnings Yield | 34.93% |
| Normalized Earnings Yield | -4.349 |